Page last updated: 2024-10-29

isocarboxazid and Appetite Disorders

isocarboxazid has been researched along with Appetite Disorders in 2 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Research Excerpts

ExcerptRelevanceReference
"In an open prospective clinical study, 14 female outpatients with anorexia nervosa or bulimia completed a 6-week trial of isocarboxazid, with a mean dose of 34 mg."7.67Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. ( Garfinkel, PE; Kennedy, SH; Piran, N, 1985)
"In an open prospective clinical study, 14 female outpatients with anorexia nervosa or bulimia completed a 6-week trial of isocarboxazid, with a mean dose of 34 mg."3.67Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. ( Garfinkel, PE; Kennedy, SH; Piran, N, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kronig, MH1
Kennedy, SH1
Piran, N1
Garfinkel, PE1

Other Studies

2 other studies available for isocarboxazid and Appetite Disorders

ArticleYear
Case report of successful treatment of bulimia with isocarboxazid.
    The American journal of psychiatry, 1986, Volume: 143, Issue:4

    Topics: Adult; Feeding and Eating Disorders; Female; Humans; Hyperphagia; Isocarboxazid; Tranylcypromine

1986
Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid.
    Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Anorexia Nervosa; Attitude to Health; Body Weight; Depressive Disorder; Feeding a

1985